Promising treatment for Ebola to be tested at Texas Biomed

(Texas Biomedical Research Institute) During the West African Ebola outbreak that began in 2013, an experimental biopharmaceutical drug called ZMappTM was a glimmer of hope in the midst of a health crisis. Now, scientists at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this promising new therapeutic.
Source: EurekAlert! - Biology - Category: Biology Source Type: news